A detailed history of Dimensional Fund Advisors LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 248,736 shares of SRRK stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
248,736
Previous 248,736 -0.0%
Holding current value
$10.3 Million
Previous $2.07 Million 3.81%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$7.84 - $16.79 $317,512 - $679,978
-40,499 Reduced 14.0%
248,736 $2.07 Million
Q1 2024

May 10, 2024

SELL
$13.2 - $17.76 $542,533 - $729,953
-41,101 Reduced 12.44%
289,235 $5.14 Million
Q4 2023

Feb 07, 2024

BUY
$6.52 - $20.32 $250,980 - $782,198
38,494 Added 13.19%
330,336 $6.21 Million
Q3 2023

Nov 09, 2023

BUY
$6.02 - $7.76 $561,274 - $723,503
93,235 Added 46.94%
291,842 $2.07 Million
Q2 2023

Aug 09, 2023

BUY
$5.79 - $9.11 $765,403 - $1.2 Million
132,194 Added 199.05%
198,607 $1.5 Million
Q1 2023

May 12, 2023

BUY
$7.36 - $12.72 $139,869 - $241,730
19,004 Added 40.09%
66,413 $531,000
Q4 2022

Feb 09, 2023

BUY
$7.02 - $9.76 $140 - $195
20 Added 0.04%
47,409 $429,000
Q3 2022

Nov 10, 2022

SELL
$5.33 - $11.3 $622,528 - $1.32 Million
-116,797 Reduced 71.14%
47,389 $329,000
Q2 2022

Aug 12, 2022

SELL
$4.66 - $13.96 $68,958 - $206,580
-14,798 Reduced 8.27%
164,186 $901,000
Q1 2022

May 13, 2022

BUY
$11.89 - $24.68 $409,206 - $849,386
34,416 Added 23.81%
178,984 $2.31 Million
Q4 2021

Feb 09, 2022

BUY
$24.14 - $35.18 $2.6 Million - $3.79 Million
107,805 Added 293.24%
144,568 $3.59 Million
Q3 2021

Nov 12, 2021

BUY
$27.38 - $42.21 $161,897 - $249,587
5,913 Added 19.17%
36,763 $1.21 Million
Q2 2021

Aug 12, 2021

BUY
$26.34 - $46.62 $812,589 - $1.44 Million
30,850 New
30,850 $892,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.13B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.